HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.

AbstractOBJECTIVE:
The objective was to determine the safety and efficacy of a fish oil-based intravenous lipid emulsion (ILE) in the treatment of parenteral nutrition-associated liver disease (PNALD).
SUMMARY AND BACKGROUND DATA:
PNALD can be a lethal complication in children with short bowel syndrome (SBS). ILE based on soybean oil administered with parenteral nutrition (PN) may contribute to its etiology.
METHODS:
We performed an open-labeled trial of a fish oil-based ILE in 42 infants with SBS who developed cholestasis (serum direct bilirubin >2 mg/dL) while receiving soybean oil-based ILE. Safety and efficacy outcomes were compared with those from a contemporary cohort of 49 infants with SBS and cholestasis whose PN course included soybean ILE only. The primary efficacy end-point was time to reversal of cholestasis (direct bilirubin <=2 mg/dL).
RESULTS:
Three deaths and 1 liver transplantation occurred in the fish oil cohort, compared with 12 deaths and 6 transplants in the soybean oil cohort (P = 0.005). Among survivors not transplanted during PN, cholestasis reversed while receiving PN in 19 of 38 patients in the fish oil cohort versus 2 of 36 patients in the soybean oil cohort. Based on Cox models, subjects receiving fish oil-based ILE experienced reversal of cholestasis 6 times faster (95% CI: 2.0-37.3) than those receiving soybean oil-based ILE. The provision of fish oil-based ILE was not associated with hypertriglyceridemia, coagulopathy, or essential fatty acid deficiency. Moreover, hypertriglyceridemic events and abnormal international normalized ratio levels were more common among controls.
CONCLUSIONS:
Fish oil-based ILE is safe, may be effective in treating PNALD, and may reduce mortality and organ transplantation rates in children with SBS.
AuthorsMark Puder, Clarissa Valim, Jonathan A Meisel, Hau D Le, Vincent E de Meijer, Elizabeth M Robinson, Jing Zhou, Christopher Duggan, Kathleen M Gura
JournalAnnals of surgery (Ann Surg) Vol. 250 Issue 3 Pg. 395-402 (Sep 2009) ISSN: 1528-1140 [Electronic] United States
PMID19661785 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Fat Emulsions, Intravenous
  • Fish Oils
  • Soybean Oil
Topics
  • Cholestasis (etiology, therapy)
  • Data Interpretation, Statistical
  • Fat Emulsions, Intravenous (adverse effects, therapeutic use)
  • Female
  • Fish Oils (adverse effects, therapeutic use)
  • Humans
  • Infant
  • Liver Function Tests
  • Liver Transplantation (statistics & numerical data)
  • Male
  • Parenteral Nutrition (adverse effects, methods)
  • Prospective Studies
  • Short Bowel Syndrome (complications, therapy)
  • Soybean Oil (adverse effects)
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: